Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and links to updates and FAQs, noting that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T16:08:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:05:11.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:07:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error HTML block, indicating restricted access to the study record rather than substantive content or updates.
    Difference
    0.5%
    Check dated 2026-09-27T21:37:56.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study page now displays a 403 error, replacing the detailed record with an access-denied message. The content visible on the page no longer includes the study description, criteria, investigators, sponsors, or location details.
    Difference
    18%
    Check dated 2026-09-20T20:48:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.